Skip to main content
OpenTrials
Completed

NCT Number: NCT00724269

Comparison of OPTI-FREE RepleniSH and ReNu Multi-Plus Lens Care Regimens on Corneal Epithelium

The purpose of this study is to evaluate the corneal epithelium after soft contact lens wear and use of two marketed multi-purpose solutions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Contact Alcon Call Center for Study Locations

Fort Worth, Texas, 76134, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Successful contact lens wear on a daily wear basis
  • Wear contact lenses at least 8 hours/day
  • Vision correctable to at least 20/30
  • Normal Eyes
  • Other protocol-defined inclusion criteria may apply

Exclusion:

  • Topical ocular medication use
  • Other protocol-defined inclusion criteria may apply

Treatment and study plan

OPTI-FREE RepleniSH

Device

Multi-Purpose Solution for soft contact lenses

ReNu MultiPlus MPS

Device

Multi-Purpose Solution for soft contact lenses

Primary outcomes

  1. Confocal microscopy analysis of Corneal Epithelium

    Time frame: 2 weeks

Secondary outcomes

  1. Patient comfort

    Time frame: 2 weeks

  2. Corneal Staining

    Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Jul 29, 2008
Registry last updated
Oct 1, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.